# Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

> **NCT02247934** · — · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 26 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02247934
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02247934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02247934, "Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02247934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*